Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 3/20 | 0.50 |
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.37 |
| ▸ | LMNA | P02545 | 5/20 | 0.34 |
| ▸ | POLB | P06746 | 1/20 | 0.34 |
| ▸ | GLA | P06280 | 1/20 | 0.33 |
| ▸ | DGKA | P23743 | 1/20 | 0.33 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.33 |
| ▸ | RAB9A | P51151 | 1/20 | 0.31 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.30 |
| ▸ | MEN1 | O00255 | 1/20 | 0.30 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.30 |
| ▸ | PAM | P19021 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL688569 | 0.93 | TSHR (0.43) | TSHRLMNADGKACYP1A2ALDH1A1 | |
| SCHEMBL16429438 | 0.90 | DGKA (0.42) | TSHRLMNADGKAALDH1A1PAM | |
| SCHEMBL718866 | 0.90 | DGKA (0.42) | TSHRLMNADGKAALDH1A1PAM | |
| SCHEMBL689240 | 0.90 | DGKA (0.42) | TSHRLMNADGKAALDH1A1PAM | |
| SCHEMBL5798257 | 0.87 | TSHR (0.46) | TSHRLMNAGLADGKACYP1A2 | |
| SCHEMBL337863 | 0.86 | TSHR (0.44) | TSHRLMNAALDH1A1 | |
| SCHEMBL11187692 | 0.83 | — | — | |
| SCHEMBL1491588 | 0.83 | — | — | |
| SCHEMBL28855208 | 0.83 | LMNA (0.58) | TSHRSLC22A6LMNAALDH1A1MEN1 | |
| SCHEMBL6714241 | 0.81 | TSHR (0.67) | TSHRLMNAGLAL3MBTL1ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 36 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-102516741-A | Method of reducing the styrene content of a poly(arylene ether)/polystyrene blend, and articles comprising the resulting thermoplastic resin | SABIC INNOVATIVE PLASTICS IP | 2012-06-27 | — | — | CN | claimed |
| CN-101313022-A | Polymer blend method, composition, and article | GEN ELECTRIC (US) | 2008-11-26 | — | — | CN | claimed |
| CN-101287799-A | Method of reducing the styrene content of poly (arylene ether)/polystyrene blends, and articles comprising the resulting thermoplastic resins | GEN ELECTRIC (US) | 2008-10-15 | — | — | CN | claimed |
| CN-1338934-A | Mono-acyloxy aralkyl neuronuscular relaxants | NEWLAXANT L L C (US) | 2002-03-06 | — | — | CN | claimed |
| CN-1280578-A | Bis-quaternary ammonium derivatives as neuromuscular relaxants | NEWLAKSONT CO LTD (US) | 2001-01-17 | — | — | CN | claimed |
| EP-1025099-A1 | BIS-QUATERNARY AMMONIUM DERIVATIVES AS NEUROMUSCULAR RELAXANTS | Gyermek, Laszlo (US) | 2000-08-09 | — | — | EP | claimed |
| WO-1999021854-A1 | BIS-QUATERNARY AMMONIUM DERIVATIVES AS NEUROMUSCULAR RELAXANTS | NEWLAXANT LLC (US) | 1999-05-06 | — | — | WO | claimed |
| US-20260115330-A1 | RADIOPAQUE MULTI-ARM POLYMERS FOR MEDICAL APPLICATIONS | BOSTON SCIENTIFIC SCIMED, INC. (US) | 2026-04-30 | — | — | US | disclosed |
| CN-109608434-A | A kind of preparation method of lenalidomide | 浙江工业大学 | 2019-04-12 | — | — | CN | disclosed |
| EP-2927250-B1 | (FUMARIC ACID DIESTER)-(CINNAMIC ACID ESTER) COPOLYMER, METHOD FOR PRODUCING SAME, AND FILM PRODUCED USING SAME | TOSOH CORP (JP) | 2017-08-16 | — | — | EP | disclosed |
| US-9512284-B2 | Fumaric acid diester-cinnamic acid ester-based copolymer, production method thereof and film using the same | TOSOH CORPORATION (JP) | 2016-12-06 | — | — | US | disclosed |
| US-9321017-B2 | Gas-separation membrane | NAGOYA INDUSTRIAL SCIENCE RESEARCH INSTITUTE (JP) | 2016-04-26 | — | — | US | disclosed |
| US-20150291751-A1 | FUMARIC ACID DIESTER-CINNAMIC ACID ESTER-BASED COPOLYMER, PRODUCTION METHOD THEREOF AND FILM USING THE SAME | TOSOH CORPORATION (JP) | 2015-10-15 | — | — | US | disclosed |
| US-5091383-A | SUBSTITUTED BRIDGED DIAZABICYCLOALKYL QUINOLONE CARBOXYLIC ACIDS | PFIZER INC. (US) | 1992-02-25 | — | — | US | disclosed |
| EP-0215650-B1 | SUBSTITUTED BRIDGED-DIAZABICYCLOALKYL QUINOLONE CARBOXYLIC ACIDS | PFIZER INC. (US) | 1992-01-29 | — | — | EP | disclosed |
| US-4861779-A | Anti-bacterial substituted bridged-diazabicycloalkyl quinolone carboxylic acids | PFIZER INC. (US) | 1989-08-29 | — | — | US | disclosed |
| US-4775668-A | Substituted bridged-diazabicycloalkyl quinolone carboxylic acids and anti-bacterial use thereof | PFIZER INC. (US) | 1988-10-04 | — | — | US | disclosed |
| EP-0215650-A2 | Substituted bridged-diazabicycloalkyl quinolone carboxylic acids | PFIZER INC. (US) | 1987-03-25 | — | — | EP | disclosed |
| US-4252529-A | AMINOPHENOL OR AMINONAPHTHOL COMPOUND WITH SUBSTITUTED FIBER-REACTIVE RADICAL | HOECHST AKTIENGESELLSCHAFT (DE) | 1981-02-24 | — | — | US | disclosed |
| US-3971379-A | Absorbent hydrophilic cellulosic product | PERSONAL PRODUCTS COMPANY (US) | 1976-07-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260115330-A1 | RADIOPAQUE MULTI-ARM POLYMERS FOR MEDICAL APPLICATIONS | KLK3, BRDT, BPHL | TSHR 689/4885SLC22A6 2025/4885LMNA 2822/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.